2018 Investment in Cancer Research: Report Released
Today, CCRA released its latest report on the investment in cancer research. It reveals that $491M was invested in cancer research in 2018. Although a slight increase since 2017 (up $17M), the investment has been fairly constant over the past five years.
This year’s report includes some new analyses, which quantify the cancer-related health services and policy research (HSPR) investment for the five-year period, 2014-2018. The investment in cancer-related HSPR represented 5% of the overall cancer research investment for this period, with a fairly stable annual amount of between $26M to $27M.
The report has an accompanying slide deck and Excel file that expand on the report analyses. To access the annual report and companion documents, click here.

CCRA members congratulate Elisabeth Baugh on her pending retirement as CEO of Ovarian Cancer Canada. Elisabeth has been at the helm of the organization since its founding. Under Elisabeth’s leadership, Ovarian Cancer Canada has grown its national presence and her commitment to women living with ovarian cancer and passion for ad...